Recent Posts
- AsclepiX Therapeutics, Inc. Appoints Robert J. Dempsey as Chief Executive Officer and President
- AsclepiX Therapeutics, Inc. Doses First Patient in Phase 1/2a Trial of AXT107 Intravitreal Self-Forming Gel Depot Peptide for Diabetic Macular Edema (DME)
- AsclepiX Therapeutics to Present at Solebury Trout Private Company Showcase on October 15, 2020
- AsclepiX Therapeutics Announces $35 Million Series A Financing
- AsclepiX Therapeutics, Inc. Expands Leadership Team with Appointment of Industry Leader Theresa Heah, MD, MBA as Chief Medical Officer.
Recent Comments